Academic perspectives on the United States food and drug administration's guidance for industry on diabetes mellitus

Epidemiology in Medicine.

Annals of Internal Medicine · 1988 · 1.9K citations

Infectious Disease Epidemiology, Preventive Medicine, Epidemiological Outcome +7

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · The Lancet · 2009 · 1.4K citations

Open-label Trial, Diabetes Management, Cardiovascular Disease +10

Discrepancies between Meta-Analyses and Subsequent Large Randomized, Controlled Trials

Jacques LeLorier, Geneviève Grégoire, A Aïssa Benhaddad et al. · New England Journal of Medicine · 1997 · 1.2K citations · Full text

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

Philip Home, Stuart Pocock, Henning Beck‐Nielsen et al. · New England Journal of Medicine · 2007 · 762 citations · Full text

The Need for Large-Scale Randomized Evidence Without Undue Emphasis on Small Trials, Meta-analyses, or Subgroup Analyses

Charles H. Hennekens · JAMA · 2009 · 148 citations

Otorhinolaryngology, Education, Surgery +19